Concepedia

Mark Sumeray

MS

Statistics

Publications

15

Citations

571

H-Index

13

Active since

1996

Affiliations

University College London(Current)

University College Hospital

Aegerion Pharmaceuticals (United States)

The Royal Melbourne Hospital

The University of Melbourne

Mark Sumeray is an author at University College London specializing in medicine, clinical pharmacology, and pharmacology.

ORCID

Publications per year

1996–2024

15

Publications

15

Infarct Size and Nitric Oxide Synthase in Murine Myocardium

Mark Sumeray, DD Rees · Journal of Molecular and Cellular Cardiology · 2000 · 109 citations

, , +13

Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study

Johannes S. Kern, Eli Sprecher, María Florencia Fernández et al. · British Journal of Dermatology · 2022 · 70 citations · Full text

, , +13

Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies

Mark Sumeray · The Lancet · 1996 · 52 citations

, , +12

Relationship of urethral retro‐resistance pressure to urodynamic measurements and incontinence severity

Mark Slack, Patrick J. Culligan, M. R. Tracey et al. · Neurourology and Urodynamics · 2004 · 50 citations

, , +16

Characterisation and validation of a murine model of global ischaemia-reperfusion injury

Mark Sumeray, Derek M. Yellon · 1998 · 42 citations

, , +7

1–5 of 15